Javascript must be enabled to continue!
Spleen-preserving pancreatectomy with splenic vessels removal : impact on splenic parenchyma ?
View through CrossRef
Abstract
Background While outcomes after spleen-preserving distal pancreatectomy (SP-DP) are widely reported, the impact on splenic parenchyma is poorly studied. This study aimed to assess splenic imaging after SP-DP with splenic vessels removal or preservation, and to compare postoperative outcomes especially spleen-related.Methods All patients undergoing SP-DP with splenic vessels removal (Warshaw technique, WDP) or preservation (Kimura technique, KDP) between 2010 and 2022 in two tertiary centres were retrospectively analysed. Splenic ischemia and volume at early/late imaging and postoperative outcomes were reviewed.Results Ninety-five patients were included, 57 in WDP and 38 in KDP groups. The median age and Charlson’s Comorbidity Index were significantly higher in WDP group compared with KDP group. Postoperative morbidity was similar between groups. There was more splenic ischemia at early imaging in WDP compared to KDP groups (53% vs. 14%, p = 0.007), especially severe ischemia (22% vs. 0). Splenic partial atrophy was observed in 30% and 0% of WDP and KDP groups, respectively (p < 0.001); no complete splenic atrophy appeared. There was no significant difference between groups in haematological parameters (haemoglobin, platelets, white blood cells and CRP levels) until postoperative day 6. Charlson Comorbidity Index and postoperative day 6 platelets levels were prognostic factors of splenic atrophy at multivariate analysis. No episodes of overwhelming post-splenectomy infection or secondary splenectomy were recorded after a median follow-up of 9 and 11 months in WDP and KDP groups, respectively.Conclusions Splenic ischemia appeared in one half of patients undergoing SP-DP with splenic vessels removal at early imaging, and partial splenic atrophy in 30% at late imaging, without clinical impact neither complete splenic atrophy. Charlson Comorbidity Index and postoperative day 6 platelets levels could help to predict the occurrence of splenic atrophy.
Research Square Platform LLC
Title: Spleen-preserving pancreatectomy with splenic vessels removal : impact on splenic parenchyma ?
Description:
Abstract
Background While outcomes after spleen-preserving distal pancreatectomy (SP-DP) are widely reported, the impact on splenic parenchyma is poorly studied.
This study aimed to assess splenic imaging after SP-DP with splenic vessels removal or preservation, and to compare postoperative outcomes especially spleen-related.
Methods All patients undergoing SP-DP with splenic vessels removal (Warshaw technique, WDP) or preservation (Kimura technique, KDP) between 2010 and 2022 in two tertiary centres were retrospectively analysed.
Splenic ischemia and volume at early/late imaging and postoperative outcomes were reviewed.
Results Ninety-five patients were included, 57 in WDP and 38 in KDP groups.
The median age and Charlson’s Comorbidity Index were significantly higher in WDP group compared with KDP group.
Postoperative morbidity was similar between groups.
There was more splenic ischemia at early imaging in WDP compared to KDP groups (53% vs.
14%, p = 0.
007), especially severe ischemia (22% vs.
0).
Splenic partial atrophy was observed in 30% and 0% of WDP and KDP groups, respectively (p < 0.
001); no complete splenic atrophy appeared.
There was no significant difference between groups in haematological parameters (haemoglobin, platelets, white blood cells and CRP levels) until postoperative day 6.
Charlson Comorbidity Index and postoperative day 6 platelets levels were prognostic factors of splenic atrophy at multivariate analysis.
No episodes of overwhelming post-splenectomy infection or secondary splenectomy were recorded after a median follow-up of 9 and 11 months in WDP and KDP groups, respectively.
Conclusions Splenic ischemia appeared in one half of patients undergoing SP-DP with splenic vessels removal at early imaging, and partial splenic atrophy in 30% at late imaging, without clinical impact neither complete splenic atrophy.
Charlson Comorbidity Index and postoperative day 6 platelets levels could help to predict the occurrence of splenic atrophy.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Spleen-preserving pancreatectomy with removal of splenic vessels: impact on splenic parenchyma ?
Spleen-preserving pancreatectomy with removal of splenic vessels: impact on splenic parenchyma ?
Abstract
Background
While outcomes after spleen-preserving distal pancreatectomy (SP-DP) have been widely reported, impac...
Association between ultrasonographic appearance of splenic parenchyma and cytology in cats
Association between ultrasonographic appearance of splenic parenchyma and cytology in cats
Objectives The purpose of this study was to determine whether the presence of a splenic mass or a diffusely moth-eaten parenchyma on ultrasonographic scans could represent potentia...
A new method to predict venous complications in pediatric liver transplantation: Evaluation of splenic parameters by ultrasonography
A new method to predict venous complications in pediatric liver transplantation: Evaluation of splenic parameters by ultrasonography
AbstractBackgroundVenous complications after pediatric liver transplantation seriously affect the survival rate of patients and grafts. At present, the diagnostic indicators have n...
Vessels from Late Medieval cemeteries in the Central Balkans
Vessels from Late Medieval cemeteries in the Central Balkans
Although a rare occurrence in late medieval cemeteries, vessels have been
found on almost all major sites of the period, such as Novo Brdo, Trgoviste,
Reljina Gradina and the...
Malignant Tumors of the Spleen
Malignant Tumors of the Spleen
Malignant tumors of the spleen are rare lesions that can be divided into three broad categories: lymphoproliferative diseases, metastatic lesions, and primary splenic (nonlymphoid)...
Malignant Tumors of the Spleen
Malignant Tumors of the Spleen
Malignant tumors of the spleen are rare lesions that can be divided into three broad categories: lymphoproliferative diseases, metastatic lesions, and primary splenic (nonlymphoid)...
Risk Factors of Pancreatic Fistula in Distal Pancreatectomy Patients
Risk Factors of Pancreatic Fistula in Distal Pancreatectomy Patients
Introduction.Benign and malignant lesions of the pancreas located at the body and tail of the pancreas are managed by the standard procedure of distal pancreatectomy (DP). The mort...

